The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

Europe Next Generation Sequencing Market Overview

The European next-generation sequencing (NGS) market is driven by technological advancements and significant developments in genomics. However, its growth is likely to be impacted by a shortage of skilled professionals and the high risks associated with genetic data privacy. Advancements in molecular biology have enhanced sequencing procedures, leading many companies to introduce innovative NGS technologies. This has contributed to the rise of the New Bioeconomy, which is replacing traditional petrochemical-based manufacturing. In 2018, Roche launched new AVENIO Tumor Tissue Analysis Kits. Other leading systems in the market include Roche’s GS FLX, Illumina’s HiSeq 2000, and AB’s SOLiD, which have dominated the industry.

Europe Next Generation Sequencing Market Strategies

Strategic insights for the European NGS market provide a data-driven analysis of the industry landscape, including trends, key players, and regional nuances. These insights offer actionable recommendations that enable businesses to differentiate themselves by finding untapped segments or creating unique value propositions. By leveraging data analytics, these insights help all stakeholders anticipate market shifts and position themselves for long-term success. A future-oriented perspective is vital for navigating this dynamic region effectively. Ultimately, these strategic insights empower readers to make informed, profitable decisions and achieve their business objectives, helping them stay ahead of the competition.

Europe Next Generation Sequencing Market Insights

The geographic scope of a business in the European NGS market refers to its specific areas of operation. Understanding local distinctions, such as diverse consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet unique local demands. A clear market focus enables more effective resource allocation and targeted marketing campaigns. This also helps in better positioning against local competitors, ultimately driving growth in those targeted areas and ensuring a more efficient and effective business strategy.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00005459

EUROPE NEXT GENERATION SEQUENCING - MARKET SEGMENTATION

By Product

• Consumables

• Services

• Platforms

By Technology

• Genome Sequencing

• Exome Sequencing

• Resequencing & Targeted Sequencing

• Other

By Application

• Diagnostics

• Drug Discovery

• Precision Medicine

• Others

By End User

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Hospitals & Clinics

• Others

By Geography

• Europe

• UK

• Germany

• France

Company Profiles

• Illumina, Inc.

• Thermo Fisher

• Qiagen N.V.,

• Beijing Genomics Institute

• PerkinElmer, Inc.

• F.Hoffman-La Roche Ltd.

• Agilent Technologies

• Eurofins Scientific

• Oxford Nanopore Technologies Ltd.

• Macrogen Inc.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications